Cytosorbents's total assets for Q3 2025 were $45.75M, a decrease of -4.67% from the previous quarter. CTSO total liabilities were $36.73M for the fiscal quarter, a 0.90% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.